SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) reported non-GAAP net income for the quarter ended June 30, 2008, of $172.7 million, or non-GAAP earnings per diluted share of $0.37. Based on U.S. Generally Accepted Accounting Principles (GAAP), Celgene reported net income of $119.9 million, or diluted earnings per share of $0.26 for the quarter ended June 30, 2008. The second quarter of 2008 included the after-tax impact of share-based employee compensation expense of $21.0 million. GAAP net income for the second quarter of 2007 was $54.9 million, or diluted earnings per share of $0.13, including the after-tax impact of share-based employee compensation expense of $12.7 million.
